Details
| Stereochemistry | MIXED |
| Molecular Formula | C21H45N3 |
| Molecular Weight | 339.6021 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1
InChI
InChIKey=DTOUUUZOYKYHEP-UHFFFAOYSA-N
InChI=1S/C21H45N3/c1-6-10-12-19(8-3)14-23-16-21(5,22)17-24(18-23)15-20(9-4)13-11-7-2/h19-20H,6-18,22H2,1-5H3
| Molecular Formula | C21H45N3 |
| Molecular Weight | 339.6021 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/11917691
Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/11917691
Hexetidine is very safe oral antiseptic with broad antibacterial and antifungal activity in vivo and in vitro. It has local-anesthetics, astringent and deodorant activity. Also, it has very strong antiplac effects. Resistention of microorganisms on hexetidine is short and transient. These characteristics give important therapeutic role in treatment of oral infections. In the UK, hexetidine is the active ingredient in the medicated mouthwash branded Oraldene. Oraldene contains 0.1 g/100 ml of hexetidine. In Germany, hexetidine is used for vaginal antisepsis.
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.1 % 1 times / day multiple, oromucosal Dose: 0.1 %, 1 times / day Route: oromucosal Route: multiple Dose: 0.1 %, 1 times / day Sources: |
unhealthy, 38.2 years (range: 18–61 years) Health Status: unhealthy Age Group: 38.2 years (range: 18–61 years) Sex: M+F Sources: |
|
10 mg 1 times / day multiple, vaginal Dose: 10 mg, 1 times / day Route: vaginal Route: multiple Dose: 10 mg, 1 times / day Sources: |
unhealthy |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The effect of hexetidine mouthwash on the prevention of plaque and gingival inflammation: a systematic review. | 2011-08 |
|
| Parotid gland swelling following mouthrinse use. | 2010-11 |
|
| The plaque inhibitory effect of a CPC mouthrinse in a 3-day plaque accumulation model - a cross-over study. | 2010-11 |
|
| Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. | 2009-09-23 |
|
| [Efficacy of an antiseptic dialysis of purulent wounds in the dentofacial region with hyvalix]. | 2008-04-18 |
|
| [Combined local therapy in oropharyngeal diseases]. | 2008 |
|
| Efficacy of vaginal misoprostol before hysteroscopy for cervical priming in patients who have undergone cesarean section and no vaginal deliveries. | 2007-12-09 |
|
| Mucocutaneous lesions of Behcet's disease. | 2007-08-31 |
|
| Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis. | 2006-07 |
|
| [Stopangin in the treatment of pharyngeal inflammation]. | 2006 |
|
| Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. | 2005-09 |
|
| Fluconazole and/or hexetidine for management of oral candidiasis associated with denture-induced stomatitis. | 2005-09 |
|
| Antiplaque and antigingivitis effectiveness of a hexetidine mouthwash. | 2003-07 |
|
| Anti-plaque agents in the prevention of biofilm-associated oral diseases. | 2003 |
|
| Antimicrobial action of Nitens mouthwash (cetyltrimethylammonium naproxenate) on multiple isolates of pharyngeal microbes: a controlled study against chlorhexidine, benzydamine, hexetidine, amoxicillin, amoxicillin-clavulanate, clarithromycin, and cefaclor. | 2002-09 |
|
| Physicochemical characterization of hexetidine-impregnated endotracheal tube poly(vinyl chloride) and resistance to adherence of respiratory bacterial pathogens. | 2002-06 |
|
| An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. | 2002-05-31 |
|
| Nonaqueous capillary electrophoretic analysis of hexetidine in a commercial liquid formulation. | 2002-04 |
|
| A comparative study in vivo of the therapeutic effect of triclosan, hexetidine and chitosan. | 2002 |
|
| [Hexetidine--an oral antiseptic]. | 2002 |
|
| The concomitant development of poly(vinyl chloride)-related biofilm and antimicrobial resistance in relation to ventilator-associated pneumonia. | 2001-10 |
|
| The erosive effects of some mouthrinses on enamel. A study in situ. | 2001-04 |
|
| [Disturbances of taste from oral disinfectants (author's transl)]. | 1978-10 |
|
| [Analytical profile of purified hexetidine (author's transl)]. | 1975 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6583906
Curator's Comment: all information about in vitro activity in german
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:59:09 GMT 2025
by
admin
on
Wed Apr 02 08:59:09 GMT 2025
|
| Record UNII |
852A84Y8LS
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C28394
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
||
|
WHO-ATC |
A01AB12
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
||
|
WHO-ATC |
G01AX16
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
||
|
WHO-VATC |
QA01AB12
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m6009
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000092531
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
D006590
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
C77049
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
5301
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | RxNorm | ||
|
205-513-5
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
141-94-6
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
Hexetidine
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
852A84Y8LS
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
3607
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
3277
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
DTXSID1045297
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
DB08958
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
522
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
7828
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
SUB08037MIG
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
17764
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY | |||
|
CHEMBL144673
Created by
admin on Wed Apr 02 08:59:09 GMT 2025 , Edited by admin on Wed Apr 02 08:59:09 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |